Four years on, long covid still confounds us. Here’s what we now know.
By Frances Stead Sellers
The Washington Post
Updated December 31, 2023 
https://www.washingtonpost.com/health/2023/12/31/long-covid-symptoms-treatment-research/

New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
December 21, 2023
https://www.medscape.com/viewarticle/new-research-aims-unravel-both-me-cfs-and-long-covid-2023a1000w9b

Bethesda, MD — New research into the mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID is aimed at identifying potential approaches to treatment of the two overlapping illnesses.

“I Finally Got My Life Back!” — How One Women Found Relief for Long COVID Fatigue
Research: COVID can cause brain changes that trigger tiredness

By Gina Roberts-Grey and Melissa Gotthardt Updated: March 24, 2024
First For Women

https://www.firstforwomen.com/posts/health/long-covid-fatigue

Are long COVID sufferers being ignored?
Implications of COVID-19 absences for employees.
31 Mar, 2024
Dr. Prajakta Banik
Tech Explorist
https://www.techexplorist.com/long-covid-sufferers-ignored/82594/

Understanding long COVID: A call for better diagnosis and treatment
By Vijay Kumar MalesuMar 7 2024
Reviewed by Susha Cheriyedath, M.Sc.
https://www.news-medical.net/news/20240307/Understanding-long-COVID-A-call-for-better-diagnosis-and-treatment.aspx

Are long COVID sufferers falling through the cracks?
Author Beth Duff-Brown
Published on March 27, 2024
Scopeblog, Stanford Medicine

https://scopeblog.stanford.edu/2024/03/27/long-covid-symptoms-sufferers-misdiagnosed/

AgelessRx Initiates Study on LDN and NAD+ as a Treatment for Long COVID Sufferers
PRESS RELEASE
Published March 27, 2024
Digital Journal

https://www.digitaljournal.com/pr/news/get-featured/agelessrx-initiates-study-ldn-nad-1641764178.html

Could Long Covid Be the Senate’s Bipartisan Cause?
Feb. 18, 2024
By Zeynep Tufekci, Opinion Columnist, New York Times

https://www.nytimes.com/2024/02/18/opinion/long-covid-research-funding.html

Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, Girish Harinath, Virginia Lee, Xingyu Zhang, Sajad Zalzala

Brain Behav Immun Health, 2024 Feb 1:36:100733. https://pubmed.ncbi.nlm.nih.gov/38352659/

Low-Dose Naltrexone Improves post-COVID-19 Condition Symptoms

Leonardo Tamariz, Elizabeth Bast, Nancy Klimas, Ana Palacio

Clin Ther, . 23rd Jan 2024:S0149-2918(24)00003-1. https://pubmed.ncbi.nlm.nih.gov/38267326/

Abstract
Purpose: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.